株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

核酸ラベリングの世界市場 - 成長、動向、予測

Nucleic Acid Labeling Market - Growth, Trends, and Forecast (2020 - 2025)

発行 Mordor Intelligence LLP 商品コード 708649
出版日 ページ情報 英文 120 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=111.91円で換算しております。
Back to Top
核酸ラベリングの世界市場 - 成長、動向、予測 Nucleic Acid Labeling Market - Growth, Trends, and Forecast (2020 - 2025)
出版日: 2020年02月01日 ページ情報: 英文 120 Pages
担当者のコメント
下記の日本語概要は、最新版レポートの内容と異なる場合があります。詳細はお問合せください。
概要

世界の核酸ラベリング市場は、2018年から2023年にかけて、9%のCAGRで拡大すると予測されています。

当レポートでは、核酸ラベリングの世界市場を調査し、市場の概要、タイプ、用途、地域別の市場動向、市場規模の推移と予測、市場促進・阻害要因ならびに市場機会の分析、競合情勢、主要企業のプロファイルなど包括的な情報を提供しています。

目次

第1章 イントロダクション

  • 市場の定義

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 主な影響要因

第5章 市場の概要

  • 市場シナリオ
  • ファイブフォース分析
    • サプライヤーの交渉力
    • 消費者の交渉力
    • 新規参入の脅威
    • 代替製品とサービスの脅威
    • 業界内での競争

第6章 市場ダイナミクス

  • 成長要因
  • 阻害要因
  • 市場機会
  • 課題

第7章 市場セグメンテーション

  • ラベルタイプ別
    • ビオチン系
    • 蛍光
    • 放射性
    • その他
  • ラベリング技法
    • ターミナルラベリング
    • ニックトランスレーション
    • ランダムプライミング
    • インビトロ転写
  • 用途別
    • ブロッティング
    • DNA塩基配列決定
    • 光原位置ハイブリッド形成
    • マイクロアレイ
    • PCR
    • その他
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中東・アフリカ
    • 南米

第8章 企業プロファイル

  • Enzo Biochem Inc.
  • GE Healthcare
  • Marker Gene Technologies Inc.
  • Merck KGaA
  • New England Biolabs Inc.
  • PerkinElmer Inc.
  • Promega Corporation
  • Thermo Fisher Scientific Inc.
  • Vector Laboratories Inc.

第9章 市場の将来展望

目次
Product Code: 64284

Personalized medicine aims to provide tailor-made therapies to individual patients, depending on the molecular basis of disease, which has become popular in recent years. Healthcare technology, genomics involving nucleic acid labeling technology, connected devices, big data analytics, and artificial intelligence are generating vast amounts of health data and insights. This is enabling healthcare providers to offer better and faster diagnoses and make more informed treatment decisions. Rising demand for personalized medicine has created tremendous opportunities in the field of genetic medicine, and in order to exploit these opportunities, novel technologies must be developed, which, in turn, has resulted in the rapid expansion of the market. Therefore, increasing focus on personalized medicine and patient-centered approach is driving the growth of the nucleic acid labeling market.

Key Market Trends

Biotin Based Segment is Expected to Show Better Growth Over the Forecast Period

Based on label type, the market is segmented into biotin-based, fluorescent, radioactive and other label types. Non-radioactively labeled probes, such as biotin-based probes have several advantages over radioactive probes, such as increased stability and their non-hazardous nature. The biotin-based labels use non-toxic materials and have faster detection rates than radioactive probes. Furthermore, owing to their long half-life and high stability, biotin-based probes can be prepared in bulk and stored at -20°C for repeated uses. Furthermore, there have been several advancements in biotin-based techniques, such as the addition of long tails of biotinylated nucleotides through enzymatic methods to counter the technique's limitations. Pertaining to these advancements, the biotin-based label segment is expected to show better growth during the forecast period.

North America is Expected to Dominate the Nucleic Acid Labeling Market

The nucleic acid labeling market dominates the North America region due to the increasing prevalence of chronic diseases, such as cancer, aging population, growing demand for targeted and personalized medicine, and favorable government initiatives. In recent years, several government initiatives have been launched, which is supplementing the growth of the nucleic acid labeling market in the United States. For instance, in 2015, the Precision Medicine Initiative was introduced to revolutionize the treatment of chronic diseases, which has accelerated the growth of the nucleic acid labeling and its acceptance as well as adoption in the region.

Competitive Landscape

The global players into the nucleic acid labeling market are Enzo Biochem Inc., GE Healthcare, Marker Gene Technologies Inc., Merck KGaA, New England Biolabs Inc., PerkinElmer Inc., Promega Corporation, Thermo Fisher Scientific and Vector Laboratories Inc.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Genomic and Enzymology Research
    • 4.2.2 Advancements in Tools for Synthetic Genome Design
    • 4.2.3 Growing Demand for Personalized Medicine
  • 4.3 Market Restraints
    • 4.3.1 Lack of Skilled Professionals
    • 4.3.2 High Cost and Complexity of Techniques
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Label Type
    • 5.1.1 Biotin-based
    • 5.1.2 Fluorescent
    • 5.1.3 Radioactive
    • 5.1.4 Other Label Types
  • 5.2 By Application
    • 5.2.1 Microarray
    • 5.2.2 DNA Sequencing
    • 5.2.3 In situ Hybridization
    • 5.2.4 Polymerase Chain Reaction
    • 5.2.5 Other Applications
  • 5.3 By End User
    • 5.3.1 Hospitals/Clinics
    • 5.3.2 Diagnostic Centers
    • 5.3.3 Others
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Enzo Biochem Inc.
    • 6.1.2 GE Healthcare
    • 6.1.3 Marker Gene Technologies Inc.
    • 6.1.4 Merck KGaA
    • 6.1.5 New England Biolabs Inc.
    • 6.1.6 PerkinElmer Inc.
    • 6.1.7 Promega Corporation
    • 6.1.8 Thermo Fisher Scientific
    • 6.1.9 Vector Laboratories Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top